| Literature DB >> 22497295 |
M M Rolf1, J F Taylor, R D Schnabel, S D McKay, M C McClure, S L Northcutt, M S Kerley, R L Weaber.
Abstract
Estimated breeding values for average daily feed intake (AFI; kg/day), residual feed intake (RFI; kg/day) and average daily gain (ADG; kg/day) were generated using a mixed linear model incorporating genomic relationships for 698 Angus steers genotyped with the Illumina BovineSNP50 assay. Association analyses of estimated breeding values (EBVs) were performed for 41,028 single nucleotide polymorphisms (SNPs), and permutation analysis was used to empirically establish the genome-wide significance threshold (P < 0.05) for each trait. SNPs significantly associated with each trait were used in a forward selection algorithm to identify genomic regions putatively harbouring genes with effects on each trait. A total of 53, 66 and 68 SNPs explained 54.12% (24.10%), 62.69% (29.85%) and 55.13% (26.54%) of the additive genetic variation (when accounting for the genomic relationships) in steer breeding values for AFI, RFI and ADG, respectively, within this population. Evaluation by pathway analysis revealed that many of these SNPs are in genomic regions that harbour genes with metabolic functions. The presence of genetic correlations between traits resulted in 13.2% of SNPs selected for AFI and 4.5% of SNPs selected for RFI also being selected for ADG in the analysis of breeding values. While our study identifies panels of SNPs significant for efficiency traits in our population, validation of all SNPs in independent populations will be necessary before commercialization.Entities:
Mesh:
Year: 2011 PMID: 22497295 PMCID: PMC3437496 DOI: 10.1111/j.1365-2052.2011.02273.x
Source DB: PubMed Journal: Anim Genet ISSN: 0268-9146 Impact factor: 3.169
Correlations between estimated breeding values computed using a GRM for N = 698 Angus steers. P-values are listed below their corresponding correlation coefficients
| RFI | ADG | |
|---|---|---|
| AFI | 0.80 | 0.53 |
| <0.0001 | <0.0001 | |
| RFI | 0.04 | |
| 0.3113 |
Numbers of SNPs exceeding the genome-wide P < 0.05 significance threshold and included in the final additive model for each analysis and percentages of EBV variance explained by the final suite of SNPs in each model computed using two different methods
| Trait | Candidate SNPs | Final model SNPs | % EBV variance | % GBLUP variance |
|---|---|---|---|---|
| AFI | 178 | 53 | 54.12 | 24.10 |
| RFI | 281 | 66 | 62.69 | 29.85 |
| ADG | 274 | 68 | 55.13 | 26.54 |
EBV variance is the model R2 from the final analysis which fits all SNPs in a fixed effects analysis.
GBLUP variance is the proportion of additive genetic variance explained by fitting all markers in a mixed model including a genomic relationship matrix for residual additive genetic effects.
Number of concordant QTL regions for AFI, RFI and ADG. Diagonals represent the numbers of forward-selected SNPs for the trait. Off-diagonals represent the number of QTL regions detected to be concordant between traits defined as overlapping QTL regions (forward-selected SNP position ± 0.5 Mb).
Summary of pathway analysis from DAVID and the KEGG Pathway Database. Numbers in each trait column are the number of genes within each specific pathway
| Trait | |||||
|---|---|---|---|---|---|
| Global pathway | Subpathway | Pathway | ADG | AFI | RFI |
| Cellular processes | Cell Communication | Adherens junction | 1 | ||
| Gap junction | 2 | ||||
| Tight junction | 3 | ||||
| Cell growth and death | Apoptosis | 1 | 1 | ||
| Cell motility | Regulation of actin cytoskeleton | 1 | 1 | ||
| Transport and catabolism | Endocytosis | 2 | |||
| Lysosome | 3 | ||||
| Regulation of autophagy | 1 | ||||
| Environmental information processing | Signal transduction | Calcium signalling pathway | 1 | 3 | |
| MAPK signalling pathway | 1 | ||||
| Notch signalling pathway | 2 | ||||
| Phosphatidylinositol signalling system | 1 | ||||
| TGF-beta signalling pathway | 2 | ||||
| Wnt signalling pathway | 1 | ||||
| Signalling molecules and interaction | Neuroactive ligand–receptor interaction | 3 | |||
| Genetic information processing | Folding, sorting and degradation | Proteasome | 1 | ||
| RNA degradation | 1 | ||||
| Ubiquitin-mediated proteolysis | 2 | ||||
| Transcription | Spliceosome | 1 | |||
| Translation | Aminoacyl-tRNA biosynthesis | 1 | |||
| Human Diseases | Cancers | Acute Myeloid Leukaemia | 1 | ||
| Chronic Myeloid Leukaemia | 1 | ||||
| Pancreatic cancer | 1 | ||||
| Pathways in cancer | 2 | 1 | |||
| Prostate cancer | 1 | ||||
| Small cell lung cancer | 1 | ||||
| Thyroid cancer | 1 | ||||
| Cardiovascular diseases | Viral myocarditis | 3 | |||
| Infectious diseases | Epithelial cell signalling in | 1 | |||
| Metabolic disorders | Type II diabetes mellitus | 1 | |||
| Neurodegenerative diseases | Alzheimer's disease | 2 | 1 | 1 | |
| Huntington's disease | 1 | 2 | |||
| Metabolism | Amino acid metabolism | Phenylalanine metabolism | 1 | ||
| Tyrosine metabolism | 1 | ||||
| Carbohydrate metabolism | Inositol phosphate metabolism | 1 | |||
| Energy metabolism | |||||
| Glycan biosynthesis and metabolism | Keratan Sulphate Biosynthesis | 1 | |||
| N-Glycan biosynthesis | 1 | ||||
| O-Glycan biosynthesis | 2 | ||||
| Lipid metabolism | Ether lipid metabolism | 1 | |||
| Glycerolipid metabolism | 1 | ||||
| Glycerophospholipid metabolism | 1 | ||||
| Metabolism of Terpenoids and Polyketides | Limonene and piene degradation | 1 | |||
| Nucleotide metabolism | Purine metabolism | 1 | |||
| Pyrimidine metabolism | 1 | ||||
| Organismal Systems | Circulatory system | Vascular smooth muscle contraction | 3 | ||
| Development | |||||
| Endocrine system | Adipocytokine signalling pathway | 1 | |||
| GnRH signalling pathway | 2 | ||||
| Insulin signalling pathway | 1 | ||||
| Melanogenesis | 1 | ||||
| Immune system | B cell receptor signalling pathway | 1 | |||
| Chemokine signalling pathway | 1 | 2 | |||
| Cytosolic DNA-sensing pathway | 1 | ||||
| Fc gamma R-mediated phagocytosis | 1 | ||||
| NOD-like receptor signalling pathway | 1 | ||||
| RIG-I-like receptor signalling pathway | 1 | 1 | |||
| T cell receptor signalling pathway | 1 | ||||
| Toll-like receptor signalling pathway | 1 | 1 | |||
| Nervous system | Long-term depression | 1 | 2 | ||
| Long-term potentiation | 1 | ||||
| Neurotrophin signalling pathway | 1 | 1 | |||
Comparison of results from this study to previously published feed efficiency QTL studies. Concordance was established if a forward-selected SNP was within ±0.5 Mb of a previously published QTL position
| Trait | SNP ID | Chr | Position (Mb) | Validation position (Mb) |
|---|---|---|---|---|
| AFI | ss86278343 | 11 | 5.660631 | 5.205392 |
| ss117964737 | 14 | 70.09761 | 70.53168 | |
| ss86295351 | 15 | 61.349658 | 60.933014 | |
| ss61538007 | 17 | 29.240631 | 28.901 | |
| ss86318895 | 19 | 49.810291 | 49.675 | |
| ss86339752 | 21 | 31.529569 | 31.455 | |
| RFI | ss61489474 | 3 | 7.649578 | 7.401859 |
| ss86274086 | 5 | 35.900142 | 36.02461 | |
| ss86290408 | 6 | 105.402482 | 105.500454 | |
| ss86341687 | 12 | 72.395434 | 72.4973 | |
| ss86295351 | 15 | 61.349658 | 60.933014 | |
| ss61538007 | 17 | 29.240631 | 28.901 | |
| ss86303118 | 21 | 30.983757 | 31.455 | |
| ADG | ss86335501 | 5 | 33.048112 | 33.304 |
| ss86298158 | 17 | 12.72016 | 12.58837 | |
| ss86289007 | 24 | 4.017728 | 4.153065 | |
| ss61547771 | 24 | 52.914946 | 52.746 |
Chromosomal positions are Btau4.0 coordinates
Validation positions are taken from the published coordinates (or SNP IDs referenced in publicly accessible databases such as dbSNP) mapped to the Btau4.0 assembly. Where no IDs or genomic positions were given, but a linkage map was referenced, positions correspond to that of the closest marker in the referenced map identified by BLAST and BLAT searches of published primer sequences.
Barendse ;
Nkrumah .